Our 1st commercial product MiBiome™ Topical Suspension approaches chronic inflammatory skin disease such as Psoriasis and Atopic Dermatitis from a whole new perspective, managing the dermal microbiome. MiBiome™ is novel patented formulation that was developed with the funding from Israeli innovation Authority, and commercially available in Israeli pharmacies and on Amazon worldwide.